Systems biology approach identifies the kinase Csnk1a1 as a regulator of the DNA damage response in embryonic stem cells

Science Signaling

Volumn 6, Issue 259, 2013, Pages

  Puigvert, Jordi Carreras ^a   Von Stechow, Louise ^a,b   Siddappa, Ramakrishnaiah ^a,b   Pines, Alex ^b,c   Bahjat, Mahnoush ^a   Haazen, Lizette C J M ^a   Olsen, Jesper V ^d   Vrieling, Harry ^c   Meerman, John H N ^a   Mullenders, Leon H F ^c   Van De Water, Bob ^a   Danen, Erik H J ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b Netherlands Toxicogenomics Centre   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d University of Copenhagen   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CASEIN KINASE; CASEIN KINASE 1 ALPHA 1; CISPLATIN; PHOSPHATASE; PROTEIN P53; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; CELL SURVIVAL; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; EMBRYONIC STEM CELL; GENE DELETION; GENE SILENCING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEOMICS; RNA INTERFERENCE; SYSTEMS BIOLOGY; TRANSCRIPTOMICS; WNT SIGNALING PATHWAY;

ANIMALS; APOPTOSIS; CASEIN KINASE I; CELL LINE; DNA DAMAGE; EMBRYONIC STEM CELLS; MICE; PLURIPOTENT STEM CELLS; RNA INTERFERENCE; SYSTEMS BIOLOGY; TRANSCRIPTOME; TUMOR SUPPRESSOR PROTEIN P53; WNT SIGNALING PATHWAY;

EID: 84872733084     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.2003208     Document Type: Article

References (50)

1. A. Ciccia, S. J. Elledge, The DNA damage response: Making it safe to play with knives. Mol. Cell 40, 179-204 (2010).
2. M. H. Sherman, C. H. Bassing, M. A. Teitell, Regulation of cell differentiation by the DNA damage response. Trends Cell Biol. 21, 312-319 (2011).
3. S. P. Jackson, J. Bartek, The DNA-damage response in human biology and disease. Nature 461, 1071-1078 (2009).
4. L. Galluzzi, L. Senovilla, I. Vitale, J. Michels, I. Martins, O. Kepp, M. Castedo, G. Kroemer, Molecular mechanisms of cisplatin resistance. Oncogene 31, 1869-1883 (2012).
5. J. H. J. Hoeijmakers, DNA damage, aging, and cancer. N. Engl. J. Med. 361, 1475-1485 (2009).
6. Y. Kee, A. D. D'Andrea, Expanded roles of the Fanconi anemia pathway in preserving genomic stability. Genes Dev. 24, 1680-1694 (2010).
7. E. M. Kass, M. Jasin, Collaboration and competition between DNA double-strand break repair pathways. FEBS Lett. 584, 3703-3708 (2010).
8. A. B. Robertson, A. Klungland, T. Rognes, I. Leiros, DNA repair in mammalian cells: Base excision repair: The long and short of it. Cell. Mol. Life Sci. 66, 981-993 (2009).
9. J. W. Harper, S. J. Elledge, The DNA damage response: Ten years after. Mol. Cell 28, 739-745 (2007).
10. J. Bartek, J. Bartkova, J. Lukas, DNA damage signalling guards against activated oncogenes and tumour progression. Oncogene 26, 7773-7779 (2007).
11. S. Arora, K. M. Bisanz, L. A. Peralta, G. D. Basu, A. Choudhary, R. Tibes, D. O. Azorsa, RNAi screening of the kinome identifies modulators of cisplatin response in ovarian cancer cells. Gynecol. Oncol. 118, 220-227 (2010).
12. N. K. Kolas, J. R. Chapman, S. Nakada, J. Ylanko, R. Chahwan, F. D. Sweeney, S. Panier, M. Mendez, J. Wildenhain, T. M. Thomson, L. Pelletier, S. P. Jackson, D. Durocher, Orchestration of the DNA-damage response by the RNF8 ubiquitin ligase. Science 318, 1637-1640 (2007).
13. J. P. MacKeigan, L. O. Murphy, J. Blenis, Sensitized RNAi screen of human kinases and phosphatases identifies new regulators of apoptosis and chemoresistance. Nat. Cell Biol. 7, 591-600 (2005).
14. R. D. Paulsen, D. V. Soni, R. Wollman, A. T. Hahn, M. C. Yee, A. Guan, J. A. Hesley, S. C. Miller, E. F. Cromwell, D. E. Solow-Cordero, T. Meyer, K. A. Cimprich, A genome-wide siRNA screen reveals diverse cellular processes and pathways that mediate genome stability. Mol. Cell 35, 228-239 (2009).
15. M. I. Aladjem, B. T. Spike, L. W. Rodewald, T. J. Hope, M. Klemm, R. Jaenisch, G. M. Wahl, ES cells do not activate p53-dependent stress responses and undergo p53-independent apoptosis in response to DNA damage. Curr. Biol. 8, 145-155 (1998).
16. K. Sabapathy, M. Klemm, R. Jaenisch, E. F. Wagner, Regulation of ES cell differentiation by functional and conformational modulation of p53. EMBO J. 16, 6217-6229 (1997).
17. V. Solozobova, A. Rolletschek, C. Blattner, Nuclear accumulation and activation of p53 in embryonic stem cells after DNA damage. BMC Cell Biol. 10, 46 (2009).
18. M. Boutros, L. P. Brás, W. Huber, Analysis of cell-based RNAi screens. Genome Biol. 7, R66 (2006).
19. A. Birmingham, L. M. Selfors, T. Forster, D. Wrobel, C. J. Kennedy, E. Shanks, J. Santoyo-Lopez, D. J. Dunican, A. Long, D. Kelleher, Q. Smith, R. L. Beijersbergen, P. Ghazal, C. E. Shamu, Statistical methods for analysis of high-throughput RNA interference screens. Nat. Methods 6, 569-575 (2009).
20. A. Pines, C. D. Kelstrup, M. G. Vrouwe, J. C. Puigvert, D. Typas, B. Misovic, A. de Groot, L. von Stechow, B. van de Water, E. H. J. Danen, H. Vrieling, L. H. F. Mullenders, J. V. Olsen, Global phosphoproteome profiling reveals unanticipated networks responsive to cisplatin treatment of embryonic stem cells. Mol. Cell. Biol. 31, 4964-4977 (2011).
21. 2 arrest response to genotoxic stress in prostate carcinoma. Oncogene 26, 1897-1909 (2007).
22. X. Guo, X. F. Wang, Signaling cross-talk between TGF-β/BMP and other pathways. Cell Res. 19, 71-88 (2009).
23. B. D. MacArthur, A. Ma'ayan, I. R. Lemischka, Systems biology of stem cell fate and cellular reprogramming. Nat. Rev. Mol. Cell Biol. 10, 672-681 (2009).
24. T. Lin, C. Chao, S. Saito, S. J. Mazur, M. E. Murphy, E. Appella, Y. Xu, p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression. Nat. Cell Biol. 7, 165-171 (2005).
25. H. Niwa, Wnt: What's needed to maintain pluripotency? Nat. Cell Biol. 13, 1024-1026 (2011).
26. K. Watanabe, X. Dai, A WNTer revisit: New faces of b-catenin and TCFs in pluripotency. Sci. Signal. 4, pe41 (2011).
27. K. H. Lee, M. Li, A. M. Michalowski, X. Zhang, H. Liao, L. Chen, Y. Xu, X. Wu, J. Huang, A genomewide study identifies the Wnt signaling pathway as a major target of p53 in murine embryonic stem cells. Proc. Natl. Acad. Sci. U.S.A. 107, 69-74 (2010).
28. F. Yi, L. Pereira, J. A. Hoffman, B. R. Shy, C. M. Yuen, D. R. Liu, B. J. Merrill, Opposing effects of Tcf3 and Tcf1 control Wnt stimulation of embryonic stem cell self-renewal. Nat. Cell Biol. 13, 762-770 (2011).
29. C. Liu, Y. Li, M. Semenov, C. Han, G. H. Baeg, Y. Tan, Z. Zhang, X. Lin, X. He, Control of β-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 108, 837-847 (2002).
30. P. Polakis, Casein kinase 1: A Wnt'er of disconnect. Curr. Biol. 12, R499-R501 (2002).
31. E. Elyada, A. Pribluda, R. E. Goldstein, Y. Morgenstern, G. Brachya, G. Cojocaru, I. Snir-Alkalay, I. Burstain, R. Haffner-Krausz, S. Jung, Z. Wiener, K. Alitalo, M. Oren, E. Pikarsky, Y. Ben-Neriah, CKIα ablation highlights a critical role for p53 in invasiveness control. Nature 470, 409-413 (2011).
32. W. Zhang, J. Yang, Y. Liu, X. Chen, T. Yu, J. Jia, C. Liu, PR55α, a regulatory subunit of PP2A, specifically regulates PP2A-mediated β-catenin dephosphorylation. J. Biol. Chem. 284, 22649-22656 (2009).
33. E. T. Strovel, D. Wu, D. J. Sussman, Protein phosphatase 2Ca dephosphorylates axin and activates LEF-1-dependent transcription. J. Biol. Chem. 275, 2399-2403 (2000).
34. S. Amit, A. Hatzubai, Y. Birman, J. S. Andersen, E. Ben-Shushan, M. Mann, Y. Ben-Neriah, I. Alkalay, Axin-mediated CKI phosphorylation of β-catenin at Ser 45: A molecular switch for the Wnt pathway. Genes Dev. 16, 1066-1076 (2002).
35. F. Gnad, J. Gunawardena, M. Mann, PHOSIDA 2011: The posttranslational modification database. Nucleic Acids Res. 39, D253-D260 (2011).
36. W. Liu, F. Xing, M. Iiizumi-Gairani, H. Okuda, M. Watabe, S. K. Pai, P. R. Pandey, S. Hirota, A. Kobayashi, Y. Y. Mo, K. Fukuda, Y. Li, K.Watabe, N-myc downstream regulated gene 1 modulates Wnt-β-catenin signalling and pleiotropically suppresses metastasis. EMBO Mol. Med. 4, 93-108 (2012).
37. A. Valbuena, S. Castro-Obregón, P. A. Lazo, Downregulation of VRK1 by p53 in response to DNA damage is mediated by the autophagic pathway. PLoS One 6, e17320 (2011).
38. J. P. Rouault, N. Falette, F. Guéhenneux, C. Guillot, R. Rimokh, Q. Wang, C. Berthet, C. Moyret-Lalle, P. Savatier, B. Pain, P. Shaw, R. Berger, J. Samarut, J. P. Magaud, M. Ozturk, C. Samarut, A. Puisieux, Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathway. Nat. Genet. 14, 482-486 (1996).
39. S. St. Clair, L. Giono, S. Varmeh-Ziaie, L. Resnick-Silverman, W. J. Liu, A. Padi, J. Dastidar, A. DaCosta, M. Mattia, J. J. Manfredi, DNA damage-induced downregulation of Cdc25C is mediated by p53 via two independent mechanisms: One involves direct binding to the cdc25C promoter. Mol. Cell 16, 725-736 (2004).
40. R. van Amerongen, R. Nusse, Towards an integrated view of Wnt signaling in development. Development 136, 3205-3214 (2009).
41. T. Sinnberg, M. Menzel, S. Kaesler, T. Biedermann, B. Sauer, S. Nahnsen, M. Schwarz, C. Garbe, B. Schittek, Suppression of casein kinase 1α in melanoma cells induces a switch in β-catenin signaling to promote metastasis. Cancer Res. 70, 6999-7009 (2010).
42. T. M. Magin, J. McWhir, D. W. Melton, A new mouse embryonic stem cell line with good germ line contribution and gene targeting frequency. Nucleic Acids Res. 20, 3795-3796 (1992).
43. J. J. C. M. Kruse, J. P. Svensson, M. Huigsloot, M. Giphart-Gassler, W. G. E. J. Schoonen, J. E. M. Polman, G. Jean Horbach, B. van de Water, H. Vrieling, A portrait of cisplatin-induced transcriptional changes in mouse embryonic stem cells reveals a dominant p53-like response. Mutat. Res. 617, 58-70 (2007).
44. A. de Vries, E. R. Flores, B. Miranda, H. M. Hsieh, C. T. M. van Oostrom, J. Sage, T. Jacks, Targeted point mutations of p53 lead to dominant-negative inhibition of wild-type p53 function. Proc. Natl. Acad. Sci. U.S.A. 99, 2948-2953 (2002).
45. S. A. Haney, Increasing the robustness and validity of RNAi screens. Pharmacogenomics 8, 1037-1049 (2007).
46. J. Villén, S. A. Beausoleil, S. A. Gerber, S. P. Gygi, Large-scale phosphorylation analysis of mouse liver. Proc. Natl. Acad. Sci. U.S.A. 104, 1488-1493 (2007).
47. J. C. Puigvert, H. de Bont, B. van de Water, E. H. J. Danen, High-throughput live cell imaging of apoptosis. Curr. Protoc. Cell Biol. Chapter 18, Unit 18.10.1-13 (2010).
48. L. Smit, A. Baas, J. Kuipers, H. Korswagen, M. van de Wetering, H. Clevers, Wnt activates the Tak1/Nemo-like kinase pathway. J. Biol. Chem. 279, 17232-17240 (2004).
49. O. Korchynskyi, P. ten Dijke, Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter. J. Biol. Chem. 277, 4883-4891 (2002).
50. S. Dennler, S. Itoh, D. Vivien, P. ten Dijke, S. Huet, J. M. Gauthier, Direct binding of Smad3 and Smad4 to critical TGFβ-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J. 17, 3091-3100 (1998).